- 专利标题： CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION THERAPEUTIC DRUG
-
申请号： US17997422申请日： 2021-04-27
-
公开(公告)号： US20230210848A1公开(公告)日： 2023-07-06
- 发明人: Takashi KOMENO , Nozomi YAMASHITA
- 申请人： FUJIFILM TOYAMA CHEMICAL CO., LTD.
- 申请人地址： JP Chuo-ku
- 专利权人： FUJIFILM TOYAMA CHEMICAL CO., LTD.
- 当前专利权人： FUJIFILM TOYAMA CHEMICAL CO., LTD.
- 当前专利权人地址： JP Chuo-ku
- 优先权： JP 20080731 2020.04.30
- 国际申请： PCT/JP2021/016737 2021.04.27
- 进入国家日期： 2022-10-28
- 主分类号： A61K31/4965
- IPC分类号： A61K31/4965 ; A61K45/06 ; A61P31/14 ; A61K31/706
摘要：
An object of the present invention is to provide a novel combination of substances showing effects against coronavirus. The present invention provides a therapeutic agent for coronavirus infection comprising a combination of a pyrazine derivative or a salt thereof and another therapeutic agent for coronavirus infection.
信息查询
